Pralatrexate

Pr(CF₃SO₃)₃ CAS#: 52093-27-3 F.W.: 588.11

Praseodymium(III) oxide

Application Used in the solid state synthesis of a remarkable ternary, reduced molybdenum oxide, Pr 4 Mo 9 O 1 8 , whose structure contains previously unknown Mo 7 , Mo 1 3 and Mo 1 9 clusters. The new cluster product is a small band gap

Application Used in the solid state synthesis of a remarkable ternary, reduced molybdenum oxide, Pr 4 Mo 9 O 1 8 , whose structure contains previously unknown Mo 7 , Mo 1 3 and Mo 1 9 clusters. The new cluster product is a small band gap

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Recombinant protein fragment of Human PRDM5 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human PRDM6 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

A cell-permeable biscarboxamidine derivative that acts as a selective inhibitor of protein arginine methyltransferase 1 (PRMT1 IC 50 = 9.5 &#181M).